Ovid Therapeutics Inc. (OVID)

Ovid Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	28.42	26.3	27.04	44.87	187.8	72.03
Short-Term Investments	9.93	26.77	78.79	84.13	-	-
Cash & Short-Term Investments	38.35	53.08	105.83	129	187.8	72.03
Cash Growth	-50.18%	-49.85%	-17.96%	-31.31%	160.71%	-6.13%
Other Receivables	-	-	-	-	-	0.14
Receivables	-	-	-	-	-	0.14
Prepaid Expenses	3.74	2.87	3.76	2.38	2.68	2.67
Other Current Assets	-	-	0	-	-	-
Total Current Assets	42.09	55.94	109.6	131.38	190.48	74.84
Property, Plant & Equipment	12.5	13.23	14.66	16.07	0.24	0.14
Long-Term Investments	20.91	20.97	17.63	5.62	1.63	-
Other Intangible Assets	-	0.09	0.2	0.22	0.26	0.32
Other Long-Term Assets	1.93	1.93	1.94	1.97	1.93	0.63
Total Assets	77.43	92.17	144.03	155.27	194.54	75.93
Accounts Payable	3.95	3.19	3.7	1.95	7.13	5.45
Accrued Expenses	2.87	5.99	6.52	4.5	7.67	12.03
Current Portion of Leases	1.38	1.34	1.25	0.53	-	-
Current Unearned Revenue	0.72	-	-	-	-	2.21
Other Current Liabilities	-	0	-	-	-	2.37
Total Current Liabilities	8.92	10.52	11.47	6.99	14.8	22.06
Long-Term Leases	12.72	13.42	14.76	16	-	-
Long-Term Unearned Revenue	-	-	-	-	-	10.17
Other Long-Term Liabilities	-	-	30	-	-	0.06
Total Liabilities	21.64	23.94	56.23	22.99	14.8	32.29
Common Stock	0.07	0.07	0.07	0.07	0.07	0.07
Additional Paid-In Capital	375.01	372.49	365.59	357.77	351.03	337.76
Retained Earnings	-319.22	-304.3	-277.87	-225.53	-171.36	-294.19
Comprehensive Income & Other	-0.07	-0.04	-	-0.04	-	-
Total Common Equity	55.79	68.23	87.8	132.27	179.75	43.63
Shareholders' Equity	55.79	68.23	87.8	132.27	179.75	43.63
Total Liabilities & Equity	77.43	92.17	144.03	155.27	194.54	75.93
Total Debt	14.1	14.76	16	16.54	-	-
Net Cash (Debt)	24.25	38.32	89.83	112.47	187.8	72.03
Net Cash Growth	-60.63%	-57.34%	-20.13%	-40.11%	160.71%	-6.13%
Net Cash Per Share	0.34	0.54	1.27	1.60	2.76	1.23
Filing Date Shares Outstanding	71.11	71.08	70.71	70.49	70.37	65.75
Total Common Shares Outstanding	71.11	71.01	70.69	70.47	70.36	65.74
Working Capital	33.17	45.42	98.13	124.39	175.68	52.78
Book Value Per Share	0.78	0.96	1.24	1.88	2.55	0.66
Tangible Book Value	55.79	68.13	87.6	132.05	179.49	43.31
Tangible Book Value Per Share	0.78	0.96	1.24	1.87	2.55	0.66
Machinery	1.53	1.53	1.46	1.42	0.5	0.32
Leasehold Improvements	0.31	0.31	0.31	0.31	-	-

Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q